The Brigham Board Review in Hematology and Oncology 2016 (Videos)

Brigham and Women’s Hospital and Oakstone Board Review: A Comprehensive Resource for Hematology and Oncology

The Brigham and Women’s Hospital and Oakstone Board Review is a comprehensive educational program designed to empower healthcare professionals with cutting-edge knowledge and best practices in the fields of hematology and oncology. This program is meticulously tailored to the specific certification requirements outlined by the American Board of Internal Medicine, ensuring its relevance and rigor.

Course Overview

The Brigham Board Review in Hematology and Oncology is a comprehensive case-based review that delves into the intricate nuances of hematologic and oncologic disorders. This intensive program provides an in-depth exploration of the clinical fundamentals of these specialties, equipping participants with the expertise necessary for successful certification or recertification.

Learning Objectives

Upon completion of this comprehensive course, participants will be equipped with the following skills and knowledge:

• Perform differential diagnosis of complex hematologic and oncologic disorders with precision
• Identify and adeptly apply current therapeutic options for various hematologic and oncologic conditions
• Evaluate and interpret up-to-date scientific literature relevant to hematology and oncology
• Demonstrate a comprehensive understanding of the pathophysiology underlying hematologic and oncologic disorders

Course Directors

This esteemed program is led by an exceptional team of experts in the fields of hematology and oncology:

• Edwin P. Alyea, III, MD
• Nancy Berliner, MD
• Ajay K. Singh, MBBS, FRCP (UK), MBA

Topics Covered

The Brigham Board Review covers a wide range of topics essential to the practice of hematology and oncology, including:

• Molecular Genetics of Cancer
• Advances in Cancer Drug Development
• Infections in Cancer Patients
• Symptom Management in Patients with Cancer
• Communication in End-of-Life Care
• Biology of Hematopoietic Stem Cell Transplantation
• Biology of Acute Leukemia and Myelodysplastic Syndromes
• Acute Leukemias
• Myelodysplastic Syndrome
• Chronic Myelogenous Leukemia
• Myeloproliferative Syndromes
• Multiple Myeloma
• Waldenstrom’s Macroglobulemia and Amyloidosis
• Low Grade Lymphomas
• High Grade Lymphomas
• Hodgkin’s Lymphoma
• Diagnosis and Treatment of Chronic Lymphatic Leukemia and Related B Cell Malignancies
• Head and Neck Cancer
• Natural History, Screening, and Surgery for Small Cell Lung Cancer
• Non Small Cell Lung Cancer
• Mesothelioma and Thymoma
• Thyroid Cancer
• Carcinoid and Pancreatic Neuroendocrine Tumors
• Esophageal and Gastric Cancer
• Pancreatic and Hepatobiliary Cancer
• Anal Cancers
• Gastrointestinal Disorders and Genetic Syndromes
• Germ Cell Tumor
• Renal and Bladder Cancer
• Prostate Cancer
• Melanoma
• Sarcomas and Gastrointestinal Stromal Tumors (GIST)
• Ovarian Cancer
• Cervical and Endometrial Cancer
• Hematopoiesis and Cytokines
• Acquired Bone Marrow Failure
• Congenital Bone Marrow Failure
• Hemophagocytic Syndromes and Immunodeficiencies
• Anemia
• Iron Deficiency and Overload
• Immune Hemolytic Anemia
• Non-immune Hemolytic Anemia
• Sickle Cell Disease
• Thalassemia and Other Hemoglobinopathies
• Disorders of Neutrophils
• Acquired Thrombocytopenias
• Hemophilia
• Von Willebrand Disease and Congenital Platelet Disorders
• Congenital and Acquired Thrombophilia
• New Oral Anticoagulants
• Transfusion Medicine

Intended Audience

This course is meticulously designed for hematology/oncology fellows, trainees, hematologists, oncologists, and internists seeking to expand their knowledge and refine their management strategies in these specialized fields. It is also an invaluable resource for candidates preparing for the ABIM subspecialty board exams in hematology or medical oncology.

Conclusion

The Brigham and Women’s Hospital and Oakstone Board Review is an indispensable resource for healthcare professionals dedicated to providing exceptional care in hematology and oncology. Its comprehensive curriculum, expert faculty, and rigorous approach empower participants to excel in their clinical practice and achieve certification or recertification success.